GENIFARM LABORATORIES INC has a total of 17 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ACUCELA INC, PELOTON THERAPEUTICS INC and COYOTE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Australia | 1 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 | |
#9 | Philippines | 1 | |
#10 | Ukraine | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Steroids | |
#4 | Heterocyclic compounds | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Zhu Shifa | 14 |
#2 | Wang Yongdong | 14 |
#3 | Huang Zhipeng | 14 |
#4 | Cao Jiyuan | 7 |
#5 | Cheng Wen | 7 |
#6 | Cao Tongxiang | 7 |
#7 | Yongdong Wang | 2 |
#8 | Shifa Zhu | 2 |
#9 | Wen Cheng | 2 |
#10 | Jiyuan Cao | 2 |
Publication | Filing date | Title |
---|---|---|
BR112017015340A2 | use of taurine in the prevention and / or treatment of diseases induced by coronavirus and / or rotavirus genus viruses | |
US2018008563A1 | Pharmaceutical composition for preventing and/or treating disease caused by coronavirus and/or rotavirus |